Member Info for xviolet

reasonable if not promising RNS
hot sector for 2023
sp super low. 5 year low, I think. this is the low for this stock.
can lead a horse etc.

wasn't there something in a recent RNS about options at 5p?
can't remember how many. they might get in the way. or not.

at least you can get cheap high quality nigiri set lunch at kinome in tottenham, london
(chef used to work at yashin).

as expected.
and must be a free trial as well as there's no mention of cost/payment etc
which is also good news.

and if that RNS drops - and if its drill plus a few extra bits and pieces of juicy data...
the sp is gonna do 35% minimum. if not more. instantly.

2m buy.
agm coming
could be soooo close to drill RNS....

That BKY noted by Troajan last week. Thats an interesting comp. Steady rise at the moment. Been reading the old RNS's - despite the dispute with Spanish Govt there have been TR-1s - peeps buying after the Spanish Govt gave them bad news. Think its one to watch.

their holding is worth about 900K? its not that much....in the great scheme of things.
also a fundraise might be necessary (but not everyone thinks that).
I guess all that keeps the sp down.

I still have some anxiety about the way corvus capital - who advised TP - were involved in CloudTag and Red Leopard both of which were delisted from AIM.

still...I can't be the only person attracted by the sp at the moment.
for me...very cautious, small buys. LTH.

good luck all.

OK. That inspires confidence!

kodal - that was a pleasant trade for me on Friday. I nearly always lose when I try and do one-day or two-hour trade...but...not on Kodal.

I'm still mainly in Michael Gentile land - watching the fella on YouTube...quietly holding and topping up Radisson, Arizona Metals, Capitan, American Pacific Mining - all gonna do OK, I hope. Some of those goldies seem to be re-rating. I might add a few to my OMI holding...even though OMI seems a very wild stock with a very odd CEO. I'm not in Afentra but people I respect are saying Afentra and CTL are worth looking at - I'm not in CTL either - but I will spread info when I get it from a reliable source.

SOG's confidence is impressive. I am invested here but I don't have that much certainty. I like the AGM. I like the people are SAR. They seem genuine and well intentioned. I would recommend anyone who is interested in this company to watch the AGM - its quieter than this board, less emotional. I'd like to see a TR-1 from a strategic type investor . But thats just me - I like to follow the TR-1s- but I can see that you can't always wait for those green lights and sometimes you have to make your own decisions.

SOG very optimistic. At AGM Tim said 1st thing was to look at the all data Sierra generated. I'm in but I'm in for the long haul.

Last thoughts before I leave a few quid here and refuse to look back for a while. Unless they mothball the company, I guess Syn start with the smallest and cheapest of the trials necessary towards proving themselves as a 'broad spectrum' anti-viral. And the US hire? That person is there to attract investment for the next stage, once that first trial starts to produce data.

There are other options/outcomes, and they have all been discussed on this board. Good luck all, see you in the Spring.

Axe

For me its not so much hope but the pleasure of gambling with (what is to me) unknown.

I like the fact that eventual outcomes of the positions I take are unknown. I don't know if that is 'hope'. It might be. I'm not bothered if every trade works out. Some do, some don't. Hope is an interesting word. I'm closer to being indifferent. But it does hurt when I lose. But I don't lose every time.

Spacman

certainly reads better than some of the juvenile trolling. reads beautifully. nice post. thanks.

And someone bought just 1 share.

The SP hasn't budged because so many people got burned. Negative sentiment. Also its hard to read the data from the P3 trial - did SYN need just a few more patients to achieve statistical significance - who the hell sitting at home with no background in pharma or stats or data can be certain. The SP hasn't budged because so many posters are nursing large losses and 'see' the company in last year's terms. If you hadn't invested previously the risk/reward case right now, with Poly at 90p average...the risk/reward case right now is quite something.

If Syn is on STRIVE the re-rate will be quite something.

It is too easy to be negative about this company. Still...some buys today. Including a 10K punt. Some people must think this is a good price for the risk/reward. Way below the average of Poly for example, at the moment.

It might cost Polygon more to sell now than it would to co-engineer (in whatever capacity, and that could be well complex) a small trial that - despite its cost - would increase the value of the asset. Just a guess.

Prof Chris on the numbers...UK hospital admissions 2022....135K Covid. I find it hard to believe the numbers were that high. Perhaps I'm reading everything incorrectly. But lots of info on her twitter feed, links etc,

"2022 saw ~135K admissions BECAUSE of Covid."

https://twitter.com/chrischirp/status/1613958771927289858